Think Locally, Act Globally:
The New Norms of Market Access
The "Davos of the Access World"
Days
Hours
Minutes
Seconds
Think Locally, Act Globally:
The New Norms of Market Access
The "Davos of the Access World"
The New Norms of Market Access
The "Davos of the Access World"
Think Locally, Act Globally:
The New Norms of Market Access
The "Davos of the Access World"
Days
Hours
Minutes
Seconds
300+ senior healthcare leaders
navigating the rapidly evolving market and patient
access landscape
navigating the rapidly evolving market and patient
access landscape
By the Numbers
- 20+sessions
- 70+expert presentations
- 12dedicated networking hours
- 1:1curated meetings
WHY ACCESS FORUM? WHY NOW?
- 300+ senior healthcare leaders will descend on New Orleans to navigate the rapidly evolving market and patient access landscape in a completely reimagined Forum experience. You will explore how the new Administration in the US is driving unprecedented policy changes and global market dynamics creating worldwide ripple effects. Mastering both local and global strategy with cross-regional execution is now essential for success.
The maelstrom demands expertise—and solutions. Patient access decisions made locally now reverberate globally, while evidence generation must resonate across continents and complex health structures.
SESSION TRACKS:
The U.S. market is experiencing significant shifts in policy, pricing, and distribution models that will define the future of access. This track invites proposals addressing topics such as:
- The impact of U.S. healthcare policy changes, including IRA, IPAY, MFN, and executive orders
- 340B reform and its implications for stakeholders across the system
- Evolving distribution models such as direct-to-consumer approaches
- The role and challenges of PBMs in shaping access and pricing
- Other U.S.-specific policy, payer, and market innovations affecting access strategies
Outside the U.S., market access landscapes are being redefined through regional collaborations, national policies, and country-specific innovations. This Track invites proposals exploring such topics as:
- Pan-European initiatives such as EuHTANet and Joint Clinical Assessment (JCA)
- Market-specific strategies and challenges in Europe, APAC, and Latin America
- Policy frameworks that influence access and reimbursement outside the U.S.
Demonstrating and communicating value is central to market access. This track focuses on how real-world evidence and innovative methodologies can substantiate product value and strengthen payer and stakeholder engagement. Sessions may cover topics such as:
- Success stories of RWE in supporting product adoption and reimbursement
- Approaches for capturing and communicating RWE effectively in product value stories
- Integrating evidence strategies across the lifecycle to drive access outcomes
- Opportunities for global collaboration and alignment in value assessment and evidence generation
Digital transformation is reshaping every aspect of healthcare access, from how evidence is generated to how patients engage with care. This track focuses on the role of digital health, AI, and new technologies in accelerating access, creating efficiencies, and demonstrating value. Sessions may cover such topics such as:
- Using AI to drive payer engagement and smarter decision-making
- Digital tools and AI innovations that enhance patient experience and engagement
- Case studies of innovative technologies immproving access and outcomes
- Opportunities and challenges in capturing the value of digital solutions
ACCESS Forum US is more
than just an event; it’s a
curated experience that
embraces quality over quantity.
than just an event; it’s a
curated experience that
embraces quality over quantity.
INTEGRATED NETWORKING
Forget the typical exhibit floor — we’ve reinvented the experience with vibrant lounges, leadership roundtables, and New Orleans–style cultural moments that spark real dialogue and guaranteed 1:1 connections. Attendance at ACCESS Forum US is intentionally limited to 400 leaders to ensure every conversation counts and every connection drives impact.
Forget the typical exhibit floor — we’ve reinvented the experience with vibrant lounges, leadership roundtables, and New Orleans–style cultural moments that spark real dialogue and guaranteed 1:1 connections. Attendance at ACCESS Forum US is intentionally limited to 400 leaders to ensure every conversation counts and every connection drives impact.
ATTENDANCE PATHWAYS
Invitation Only
Hosted Leaders
Traditional Registration
Limited Paid Passes
AGENDA
EVENT SCHEDULE
PRE-CONFERENCE
12:00 - 19:00
Registration Desk Open
09:00 - 18:00
Executive Training Program: What you need to know to prepare for & oversee your Joint Clinical Assessment (JCA) Activities
As Joint Clinical Assessments (JCAs) redefine evidence expectations across Europe, understanding their strategic impact has become essential for global access success. This intensive, hands-on training equips Market Access, HEOR, and Evidence leaders with the knowledge, frameworks, and case insights needed to anticipate, align, and operationalize JCA readiness across teams and portfolios.
14:00 - 18:00
World Access Consortium (Invitation Only)
Coffee Break service & Working Lunch provided.
16:00 - 16:30
Coffee Break
Shared coffee break for the 2 Short Courses for 120 pax
19:00 - 21:00
An Evening in The Big Easy: ACCESS Forum Opening Reception
Kick off ACCESS Forum 2026 in true New Orleans fashion! Enjoy live music, entertainment, and hearty food stations featuring local NOLA favorites, alongside cocktails and great company. Connect with colleagues—both familiar and new—in an atmosphere that captures the spirit of the city and the excitement of the Forum ahead.
CONFERENCE DAY 1
06:00 - 08:00
Networking Lounge Final Move-Ins
07:00 - 17:00
Registration Desk Open
08:00 - 09:00
Breakfast, 1:1 Meetings & Network Lounges
09:00 - 09:15
Welcome Remarks
Joseph Boswell, President, ACCESS Forum
09:15 - 10:00
Keynote Presentation
Inma Hernandez, Senior Advisor for Drug Prices, Centers for Medicare and Medicaid Services (CMS)
10:00 - 11:00
Plenary 1: Ground Zero: The Global Policy Interconnection—Think Locally, Act Globally—The Policy Edition
Overview: Local and regional policy shifts are increasingly shaping global access strategies, with ripple effects that extend far beyond their borders. From tariffs and MFN to IRA and JCA, decisions made in one market can trigger secondary and even tertiary impacts across others. This session explores how manufacturers can anticipate and manage these interdependencies, balance regional and global priorities, and apply best practices to thrive in an environment where every local move carries global consequences.
11:00 - 11:45
Morning Break, 1:1 Meetings & Networking Lounges
11:00 - 11:45
Parallel Sessions: Interactive Workshops & Panel Discussions (Choose 1 to attend)
Policy in Practice: Regional Dynamics &
Global Reverberations
WS1: Navigating the MFN Landscape: Implications for Future Product Launches |
WS2: These 'Dis-United States': Rethinking Market Access Strategies When State Policy Defines Access |
WS3: Free-Loading vs. Free-Riding Under Most-Favored Nation Pricing |
WS4: Policy Power Players: How Industry Voices Are Shaping Global Access in a Post-Election Era |
MedTech Session 1: TBA |
13:00 - 14:30
Lunch, 1:1 Meetings & Networking Lounges
14:30 - 15:45
Parallel Sessions: Interactive Workshops & Panel Discussions (Choose 1 to attend)
Tools & Transformation—Adapting to the New Normal
WS5: Successful Use Cases of Generative AI in Market Access |
WS6: The GVD is Dead, Now What? Novel Approaches to Global/Local Collaboration |
WS7: HEORAMA – HEOR and Market Access Optimization for Commercial Success |
WS8: The Need for Speed: Navigating MFP, MFN, and Pricing Pressure with AI-Driven Scenario Planning |
MedTech Session 2: TBA |
15:45 - 16:30
Afternoon Break, 1:1 Meetings & Networking Lounges
16:30 - 17:30
Plenary 2: The Price of Innovation: How Global Access Policies Are Reshaping Drug Development
Overview: Rising pricing and reimbursement pressures are transforming how companies prioritize, fund, and launch new therapies. This session convenes leaders from pharma, biotech, and the investment community to examine how evolving access frameworks and policy reforms are influencing R&D focus, pipeline sustainability, and capital allocation. Participants will gain practical insights into how industry stakeholders are adapting strategies to balance innovation, affordability, and long-term value in a rapidly changing global market.
18:00 - 20:30
Mardi Gras Nights! Offsite Reception in the French Quarter
Feel the rhythm of New Orleans as we march down Bourbon Street toward our exclusive offsite reception—where the energy of Mardi Gras comes alive in one of the French Quarter’s most beautiful venues. Enjoy an evening of live music, vibrant entertainment, and gourmet food stations that celebrate the city’s diverse cultures. It’s an elegant, free-flowing celebration of connection, flavor, and the unmistakable spirit of NOLA.
Conference Day 2
07:00 - 15:30
Registration Desk Open
08:00 - 08:45
Breakfast, 1:1 Meetings & Networking Lounges
08:00 - 08:45
BR1: Pivot Points: Evolving Your Market Access Career for the Future
This session explores how market access careers are transforming as the function becomes more strategic and interconnected. Executive search and industry leaders will discuss the skills shaping success today, the growing role of AI and data fluency, and pathways for advancing—whether moving from local to global roles or into broader commercial leadership.
08:45 - 9:00
Welcome Remarks
Joseph Boswell, President, ACCESS Forum
09:00 - 10:00
Plenary 3: TBA November 18
10:00 - 10:30
Transition Break
10:30 - 11:45
Parallel Sessions: Interactive Workshops & Panel Discussions (Choose 1 to attend)
Value, Evidence, & Economic Sustainability
WS9: Health Technology Assessment of Biosimilars: Unlocking Potential to Improve Outcomes and Lower Costs |
WS10: MFP Effectuation and 340B Rebate Model Learnings Multidisciplinary Panel |
WS11: Global Market Access in Flux: How Regional Trends Are Shaping Each Other |
WS12: TBA |
MedTech Session 3: TBA |
11:45 - 12:45
Lunch, 1:1 Meetings & Networking Lounges
12:45 - 14:00
Parallel Sessions: Interactive Workshops & Panel Discussions (Choose 1 to attend)
Alternative Pathways—Setting the Table for Direct Models
WS13: TrumpRx and Direct to Patient Sales |
WS14: Illuminating the Patient Journey Between Clinical Visits |
WS15: US Access Workforce 2030: An Open Discussion to Outline a Career Development and Upskilling Roadmap |
WS16: TBA |
14:00 - 14:30
Transition Break
14:30 - 15:30
Plenary 4: TBA November 20
15:30 - 15:45
Conclusion & Adjournment
Sessions at a Glance
Don't miss these just-confirmed sessions at ACCESS Forum US '26! Check for updates and
confirmed speakers here.
confirmed speakers here.
- Successful Use Cases of Generative AI in Market Access: From Hype to Real-World ImpactDigital Health & AI
This session highlights proven applications of generative AI across leading pharmaceutical organizations—spanning evidence synthesis, payer communication, HTA submissions, and access strategy optimization. Speakers will share practical lessons, governance approaches, and best practices demonstrating how AI enhances efficiency, transparency, and decision-making across the product lifecycle. - Illuminating the Patient Journey Between Clinical VisitsEvidence & Value
This workshop examines how real-world connectivity data, wearables, and behavioral insights reveal the patient experience between clinical visits. Cross-stakeholder experts will discuss how these continuous data sources enhance understanding of adherence, outcomes, and quality of life—creating measurable value for manufacturers, payers, clinicians, and patients alike. - Free-Loading vs Free-Riding Under Most-Favored Nation Pricing: What Are Options for Countries to Carry Their Weight?Global & Regional Market Access (ex-U.S.)
This session explores global inequities in financing pharmaceutical innovation, examining how differential country contributions, pricing policies, and access delays affect R&D sustainability. Panelists will share findings from PhRMA and leading consultancies and discuss policy options to balance fairness, access, and shared responsibility across nations. - Global Market Access is Flux: How Regional Trends are Shaping Each OtherGlobal & Regional Market Access (ex-U.S.)
This session examines how policy and pricing reforms across the U.S., Europe, and emerging markets are influencing one another. Experts will discuss global interdependencies—from IRA and MFN pricing to the EU JCA and Beneluxa—and share strategies for navigating evolving access frameworks and cross-regional impacts. - The GVD is Dead, Now What? Novel Approaches to Global/Local Collaboration for AccessGlobal & Regional Market Access (ex-U.S.)
As traditional market access tools lose relevance, global teams are rethinking how to support affiliates effectively. This interactive workshop explores innovative collaboration models, smarter access tools, and emerging technologies that help local teams deliver stronger payer value propositions and drive efficient, country-specific access strategies. - The Price of Innovation: How Global Access Policies Are Reshaping Drug DevelopmentGlobal & Regional Market Access (ex-U.S.)
This panel examines how evolving pricing frameworks, reimbursement challenges, and policy reforms are influencing R&D priorities and investment decisions. Experts from pharma, biotech, and finance will discuss how these forces are reshaping innovation, commercialization strategies, and global patient access in an increasingly constrained market environment. - Health Technology Assessment of Biosimilars—Unlocking the Potential to Improve Patient Outcomes and Lower Costs Through Updated Treatment PathwaysU.S. Policy & Market Access
This session explores how current HTA frameworks and treatment pathways may undervalue biosimilars’ potential to expand access and improve outcomes. Experts will examine international approaches, policy gaps, and practical strategies to optimize biosimilar adoption, align pricing with value, and ensure patients benefit from post-expiry innovation. - MFP Effectuation and 340B Rebate Model Learnings Multidisciplinary PanelU.S Policy & Market Access
This panel unites experts from manufacturers, pharmacies, and hospitals to discuss the intersection of MFP implementation and the evolving 340B Pilot Program. Panelists will examine regulatory, operational, and compliance challenges while sharing collaborative strategies to balance financial sustainability with improved patient access and community health. - These "Dis-United States:" Rethinking Market Access Strategies When State Policy Defines AccessU.S. Policy & Market Access
As state-level policymaking increasingly shapes patient access, this session explores how market access teams can navigate a fragmented environment. Panelists will discuss emerging state trends, data-driven prioritization, and cross-functional strategies to align engagement, contracting, and patient-support programs with diverse and evolving state policy landscapes. - TrumpRx and Direct-to-Patient SalesU.S. Policy & Market Access
With the rise of Lilly Direct and the launch of TrumpRx, direct-to-patient commercial models are reshaping U.S. market access. This session examines emerging opportunities and challenges—from pricing and channel strategy to payer impact and brand control—as manufacturers evaluate whether, when, and how to engage in direct patient sales. - Pivot Points: Evolving Your Market Access Career for the FutureU.S. Policy & Market Access
This session explores how market access professionals can expand their influence and leadership through strategic career moves. Senior leaders and executive search experts will discuss transitions across global, local, and commercial roles—highlighting opportunities, trade-offs, and how access expertise drives broader organizational impact and executive growth.
Our Sponsoring Partners
Join our distinguished Sponsoring Partners!
Interested in partnering?
Where patient access meets global strategy. Where evidence drives decisions.
Where leaders shape tomorrow.